Ligand and Agenus Enter Into $100M Royalty Financing Agreement
Ligand Pharmaceuticals and Agenus Inc. announced that the companies have entered into a royalty financing agreement to support Agenus’ key development initiatives in the ongoing BOT/BAL clinical development program, including its planned confirmatory …